$19.670
+0.222 (+1.13%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
TAK Prediction & Forecast by Similar Chart Analysis
Alphio's TAK stock price prediction model matches the current Takeda Pharmaceutical Co Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $19.49 (-0.92%). The 1-week path is $19.98 (+1.59%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Takeda Pharmaceutical Co Ltd Stock?
Takeda Pharmaceutical Co Ltd is a good buy right now, with a current price of 19.67 and a strong year-to-date change of +25.93%. The stock has shown resilience with a 5-day change of +5.02%, and the upcoming FDA decision on Zasocitinib could further boost its prospects. However, the main risk lies in its recent earnings volatility, as seen in the last quarter where the EPS was reported at 0.48, exceeding the estimate of 0.41, but still reflecting fluctuations in net income.
TAK stock price ended at $19.67 on Friday, after rising +1.13%
Takeda Pharmaceutical Co Ltd (TAK) last closed at $19.67, gaining +1.13%. These facts feed the 1-day and 1-week TAK price prediction above.
Forecast Drivers
Takeda Pharmaceutical Co Ltd (TAK) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches TAK, ranked by similarity.
Seasonality analysis for TAK
Historically the probability of a positive October return for TAK is 60.34%. September offers the highest probability of a positive month at 98.39%, while November is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for TAK
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $14.50 | $17.26 | $18.76 | -12.26% |
| Nov 2026 | $14.53 | $15.84 | $18.46 | -19.48% |
| Dec 2026 | $14.78 | $16.05 | $18.07 | -18.41% |
In 2026, Takeda Pharmaceutical Co Ltd (TAK) is projected to range from $14.50 to $18.76.
Takeda Pharmaceutical Co Ltd 2026 monthly forecast
In Oct 2026, Takeda Pharmaceutical Co Ltd is projected to average $17.26, with a low of $14.50 and high of $18.76.
In Nov 2026, Takeda Pharmaceutical Co Ltd is projected to average $15.84, with a low of $14.53 and high of $18.46.
In Dec 2026, Takeda Pharmaceutical Co Ltd is projected to average $16.05, with a low of $14.78 and high of $18.07.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.